After Seelos Therapeutics’ amyotrophic lateral sclerosis (ALS) candidate failed a phase 2/3 study, the biotech has filed for ...

Dannce.ai emerged from stealth with a platform that aims to use artificial intelligence to help diagnose and monitor movement ...

Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.

The world's largest ALS patient-derived stem cell and biodata repository is now available to researchers globally.

The groundbreaking physicist not only made a splash by discovering that black holes emit radiation, but also as a pop-culture ...

A grant from the ALS Association will fund an early-stage clinical trial to test Tiziana's foralumab nasal spray in 20 ALS ...

I pray that she carries the love that she felt tonight every day that she has," said friend Rita Monteiro, who organized the ...

Canadian neurosurgeons in partnership with Elon Musk's Neuralink have regulatory approval to recruit six patients with ...

Eli Lilly and Verge Genomics advance ALS drug development with validated targets and a Phase 1B study, part of their $694 ...

The Japan Early-stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) is an investigator-initiated study conducted ...